Successful autologous stem cell collection with filgrastim and plerixafor after long-term lenalidomide therapy for multiple myeloma

od Agarwal, Rishi, Abidi, Muneer H.
Izdano 2012

More evidence for shortening antibiotic therapy in peritonitis: the DURAPOP trial

od Abidi, Hira H., Sawyer, Robert G.
Izdano u J Thorac Dis (2018)

POEMS Syndrome Presentation with an Abscess within the Plasmacytoma—A Rare Case Report

od Agarwal, Rishi, Abidi, Muneer H., Grandhi, Bala
Izdano 2011

Optimization of cAMP fluorescence dataset from ACTOne cannabinoid receptor 1 cell line

od Presley, Chaela S., Abidi, Ammaar H., Moore, Bob M.
Izdano u Data Brief (2016)

Revisiting respiratory syncytial virus’s interaction with host immunity, towards novel therapeutics

od Efstathiou, C., Abidi, S. H., Harker, J., Stevenson, N. J.
Izdano u Cell Mol Life Sci (2020)

Burden of Communicable Disease among the Native and Repatriating Afghans

od Abidi, Syed H., Ali, Farwa, Shah, Farida, Abbas, Farhat, Ali, Syed
Izdano 2012

Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan

od Abidi, Syed H, Sherwani, Sikandar K, Siddiqui, Tarrunum R, Bashir, Asma, Kazmi, Shahana U
Izdano 2013

Nonabsorbable Corticosteroids Use in the Treatment of Gastrointestinal Graft-versus-Host Disease

od Ibrahim, Rami B., Abidi, Muneer H., Cronin, Simon M., Lum, Lawrence G., Al-Kadhimi, Zaid, Ratanatharathorn, Voravit, Uberti, Joseph P.
Izdano 2009

Aprepitant for prevention of nausea and vomiting secondary to high-dose Cyclophosphamide administered to patients undergoing Autologous Peripheral Blood Stem Cells mobilization: A...

od Abidi, Muneer H, Tageja, Nishant, Ayash, Lois, Abrams, Judith, Ratanatharathorn, Voravit, Al-Khadimi, Zaid, Lum, Lawrence, Cronin, Simon, Ventimiglia, Marie, Uberti, Joseph
Izdano 2011

Selective Vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury

od Marmarou, Christina R., Liang, Xiuyin, Abidi, Naqeeb H., Parveen, Shanaz, Taya, Keisuke, Henderson, Scott C., Young, Harold F., Filippidis, Aristotelis S., Baumgarten, Clive M.
Izdano u Brain Res (2014)

Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)

od Zonder, Jeffrey A., Crowley, John, Hussein, Mohamad A., Bolejack, Vanessa, Moore, Dennis F., Whittenberger, Brock F., Abidi, Muneer H., Durie, Brian G. M., Barlogie, Bart
Izdano 2010

Melphalan 180 mg/m2 Can Be Safely Administered As Conditioning Regimen before an Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma Patients with Creatinine Clearance...

od Abidi, Muneer H., Agarwal, Rishi, Ayash, Lois, Deol, Abhinav, Al-Kadhimi, Zaid, Abrams, Judith, Cronin, Simon, Ventimiglia, Marie, Lum, Lawrence, Zonder, Jeffrey, Ratanatharathorn, Voravit, Uberti, Joseph
Izdano 2012

Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma

od Bhutani, Divaya, Zonder, Jeffrey, Valent, Jason, Tageja, Nishant, Ayash, Lois, Deol, Abhinav, Al-Kadhimi, Zaid, Abrams, Judith, Lum, Lawrence, Ratanatharathorn, Voravit, Uberti, Joseph, Abidi, Muneer H.
Izdano 2013

Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma

od Abidi, Muneer H., Gul, Zartash, Abrams, Judith, Ayash, Lois, Deol, Abhinav, Ventimiglia, Marie, Lum, Lawrence, Mellon-Reppen, Stephanie, Al-Kadhimi, Zaid, Ratanatharathorn, Voravit, Zonder, Jeffrey, Uberti, Joseph
Izdano 2012

A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with N...

od Abidi, Muneer H., Agarwal, Rishi, Tageja, Nishant, Ayash, Lois, Deol, Abhinav, Al-Kadhimi, Zaid, Abrams, Judith, Cronin, Simon, Ventimiglia, Marie, Lum, Lawrence, Ratanatharathorn, Voravit, Zonder, Jeffrey, Uberti, Joseph
Izdano 2012

Cancer and Treatment Distress (CTXD) Psychometric Evaluation over Time: a BMT CTN 0902 Secondary Analysis

od Syrjala, Karen L., Sutton, Steven K., Jim, Heather S.L., Knight, Jennifer M., Wood, William A., Lee, Stephanie J., Jacobsen, Paul B., Abidi, Muneer H., Yi, Jean C.
Izdano u Cancer (2016)

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cel...

od Durie, Brian G M, Hoering, Antje, Abidi, Muneer H, Rajkumar, S Vincent, Epstein, Joshua, Kahanic, Stephen P, Thakuri, Mohan, Reu, Frederic, Reynolds, Christopher M, Sexton, Rachael, Orlowski, Robert Z, Barlogie, Bart, Dispenzieri, Angela
Izdano u Lancet (2016)

Targeting CD138−/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity

od Lum, Lawrence G., Thakur, Archana, Kondadasula, Sri Vidya, Al-Kadhimi, Zaid, Deol, Abhinav, Tomaszewski, Elyse N., Yano, Hiroshi, Schalk, Dana L., Ayash, Lois, Zonder, Jeffrey A., Uberti, Joseph P., Abidi, Muneer H., Ratanatharathorn, Voravit
Izdano u Biol Blood Marrow Transplant (2016)

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously...

od Durie, Brian G. M., Hoering, Antje, Sexton, Rachael, Abidi, Muneer H., Epstein, Joshua, Rajkumar, S. Vincent, Dispenzieri, Angela, Kahanic, Stephen P., Thakuri, Mohan C., Reu, Frederic J., Reynolds, Christopher M., Orlowski, Robert Z., Barlogie, Bart
Izdano u Blood Cancer J (2020)

Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma

od Ailawadhi, Sikander, Sexton, Rachael, Lentzsch, Suzanne, Abidi, Muneer H., Voorhees, Peter M., Cohen, Adam D., Rohren, Eric, Heitner, Stephen, Kelly, Kevin, Mackler, Niklas J., Baer, David M., Hoering, Antje, Durie, Brian G., Orlowski, Robert Z.
Izdano u Clin Cancer Res (2020)